These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 16023516)

  • 41. The neurobiology of attention deficit/hyperactivity disorder.
    Curatolo P; Paloscia C; D'Agati E; Moavero R; Pasini A
    Eur J Paediatr Neurol; 2009 Jul; 13(4):299-304. PubMed ID: 18644740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
    Rostain AL
    Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attention-deficit/hyperactivity disorder, conduct disorder, and young adult intimate partner violence.
    Fang X; Massetti GM; Ouyang L; Grosse SD; Mercy JA
    Arch Gen Psychiatry; 2010 Nov; 67(11):1179-86. PubMed ID: 21041619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hereditary factors in attention deficit hyperactivity disorder].
    Fliers EA; Franke B; Buitelaar JK
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1726-9. PubMed ID: 16114287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inattention and hyperactivity predict alterations in specific neural circuits among 6-year-old boys.
    Qiu A; Rifkin-Graboi A; Tuan TA; Zhong J; Meaney MJ
    J Am Acad Child Adolesc Psychiatry; 2012 Jun; 51(6):632-41. PubMed ID: 22632622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Attention deficit hyperactivity disorder outcome in adults].
    Bange F
    Arch Pediatr; 2011 Jul; 18(7):831-4. PubMed ID: 21652189
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Review of attention-deficit/hyperactivity disorder comorbid with oppositional defiant disorder.
    Hazell P
    Australas Psychiatry; 2010 Dec; 18(6):556-9. PubMed ID: 21117844
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Attention deficit hyperactivity disorder].
    Cunill R; Castells X
    Med Clin (Barc); 2015 Apr; 144(8):370-5. PubMed ID: 24787685
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurobiology of attention-deficit hyperactivity disorder.
    Faraone SV; Biederman J
    Biol Psychiatry; 1998 Nov; 44(10):951-8. PubMed ID: 9821559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Attention-deficit hyperactivity disorder--etiology, diagnosis, and management.
    Shealy AH
    J Child Adolesc Psychiatr Nurs; 1994; 7(2):24-36. PubMed ID: 8000778
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular genetics of attention-deficit hyperactivity disorder (ADHD): an update.
    Shastry BS
    Neurochem Int; 2004 Jun; 44(7):469-74. PubMed ID: 15209415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Attention-deficit hyperactivity disorder: risk factors, protective factors, health supply, quality of life. A brief review].
    Huss M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Jun; 51(6):602-5. PubMed ID: 18446300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D's Molecular Action Mechanism in Attention-Deficit/ Hyperactivity Disorder: A Review of Evidence.
    Saedisomeolia A; Samadi M; Gholami F; Seyedi M; Effatpanah M; Hashemi R; Abdolahi M; Honarvar NM
    CNS Neurol Disord Drug Targets; 2018; 17(4):280-290. PubMed ID: 29714151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Relationship between Food Insecurity and Symptoms of Attention-Deficit Hyperactivity Disorder in Children: A Summary of the Literature.
    Lu S; Perez L; Leslein A; Hatsu I
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30893802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention-deficit hyperactivity disorder.
    Thapar AK; Thapar A
    Br J Gen Pract; 2003 Mar; 53(488):225-30. PubMed ID: 14694701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Animal models of attention-deficit hyperactivity disorder (ADHD).
    Rahi V; Kumar P
    Int J Dev Neurosci; 2021 Apr; 81(2):107-124. PubMed ID: 33428802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.